Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar.
Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
Front Endocrinol (Lausanne). 2021 Mar 30;12:641361. doi: 10.3389/fendo.2021.641361. eCollection 2021.
Gestational Diabetes Mellitus (GDM) development is related to underlying metabolic syndrome that is associated with elevated complement C3 and C4. Elevated C3 levels have been associated with preeclampsia and the development of macrosomia.
This case-control study included 34 pregnant women with GDM and 16 non-diabetic (ND) women in their second trimester. Complement-related proteins were measured and correlated with demographic, biochemical, and pregnancy outcome data.
GDM women were older with a higher BMI (p<0.001); complement C3, C4 and Factor-H were significantly elevated (p=0.001, p=0.05, p=0.01, respectively). When adjusted for age and BMI, Complement C3 (p=0.04) and Factor-H (p=0.04) remained significant. Partial correlation showed significant correlation between C4 with serum alanine aminotransferase (ALT) (p<0.05) and 2 term diastolic blood pressure (p<0.05); Factor-H and C-reactive protein (CRP; p<0.05). Pearson bivariate analysis revealed significant correlations between C3, C4, and Factor-H and CRP; p<0.05; C3 and gestational age at delivery (GA; p<0.05); C4 and ALT and second-trimester systolic blood pressure (STBP) (p=0.008 and p<0.05, respectively); Factor-H and glycated hemoglobin (HbA1c) (p<0.05). Regression analysis showed that the elevation of C3 could be accounted for by age, BMI, GA and CRP, with CRP being the most important predictor (p=0.02). C4 elevation could be accounted for by ALT, CRP and STBP. CRP predicted Factor-H elevation.
The increased C3, C4 and Factor-H during the second trimester of pregnancy in GDM are not independently associated with GDM; inflammation and high BMI may be responsible for their elevation. The elevation of second trimester C3 in GDM is associated with earlier delivery and further work is needed to determine if this is predictive.
妊娠糖尿病(GDM)的发展与潜在的代谢综合征有关,这种综合征与补体 C3 和 C4 升高有关。C3 水平升高与先兆子痫和巨大儿的发生有关。
这项病例对照研究纳入了 34 名患有 GDM 的孕妇和 16 名处于妊娠中期的非糖尿病(ND)女性。测量了补体相关蛋白,并将其与人口统计学、生化和妊娠结局数据相关联。
GDM 女性年龄较大,BMI 较高(p<0.001);补体 C3、C4 和因子-H 显著升高(p=0.001、p=0.05、p=0.01)。当按年龄和 BMI 调整后,补体 C3(p=0.04)和因子-H(p=0.04)仍然有意义。偏相关分析显示 C4 与血清丙氨酸氨基转移酶(ALT)(p<0.05)和 2 期舒张压(p<0.05)之间存在显著相关性;因子-H 和 C 反应蛋白(CRP;p<0.05)。Pearson 双变量分析显示 C3、C4 和因子-H 与 CRP 之间存在显著相关性;p<0.05;C3 与分娩时的孕龄(GA;p<0.05);C4 与 ALT 和孕中期收缩压(STBP)(p=0.008 和 p<0.05);因子-H 和糖化血红蛋白(HbA1c)(p<0.05)。回归分析显示,C3 的升高可以用年龄、BMI、GA 和 CRP 来解释,其中 CRP 是最重要的预测因子(p=0.02)。C4 的升高可以用 ALT、CRP 和 STBP 来解释。CRP 预测了因子-H 的升高。
GDM 妊娠中期 C3、C4 和因子-H 的升高与 GDM 本身并不独立相关;炎症和高 BMI 可能是其升高的原因。GDM 中妊娠中期 C3 的升高与更早的分娩有关,需要进一步研究以确定其是否具有预测性。